0001354457-18-000267.txt : 20180719
0001354457-18-000267.hdr.sgml : 20180719
20180719090321
ACCESSION NUMBER: 0001354457-18-000267
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20180719
DATE AS OF CHANGE: 20180719
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Rosetta Genomics Ltd.
CENTRAL INDEX KEY: 0001362959
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33042
BUSINESS ADDRESS:
STREET 1: 10 PLAUT STREET, SCIENCE PARK
STREET 2: POB 4059
CITY: REHOVOT
STATE: L3
ZIP: 76706
BUSINESS PHONE: 972-73-222-0700
MAIL ADDRESS:
STREET 1: 10 PLAUT STREET, SCIENCE PARK
STREET 2: POB 4059
CITY: REHOVOT
STATE: L3
ZIP: 76706
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001362959
Rosetta Genomics Ltd.
001-33042
10 Plaut Street, Science Park
P.O. Box 4059
Rehovot
L3
ISRAEL
76706
972-73-222-0700
Ordinary Shares
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2018-07-19
EX-99.25
2
rosgdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
July 19, 2018, Rosetta Genomics Ltd. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the ordinary shares of Rosetta Genomics Ltd.
(the Company), effective at the opening of the trading
session on July 30, 2018. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5920(c)(1).
The Company was notified of the Staffs determination on
April 16, 2018. The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
May 18, 2018, denying the Company continued listing
and notified the Company that trading in the Companys
securities would be suspended on May 22, 2018.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on July 2, 2018.